AG1 account plan
Nutritional supplements for health
At a glance
AG1 (formerly Athletic Greens) is a privately held daily-nutrition brand, reported at approximately $600 million in revenue over the past 16 years.
AG1 (formerly Athletic Greens) is a global nutrition company founded in 2010, best known for AG1, a daily health drink that combines a multivitamin, pre and probiotics and phytonutrients. It sold direct to consumer for 15 years and began retail with Costco in 2025. It is privately held and independent: the CEO says the founder bootstrapped it and took no outside capital. It publishes no annual accounts in the documents reviewed, so revenue figures come from press reports and executive statements, such as close to $160 million in 2021 and approximately $600 million over the past 16 years, according to a 2024 projection shared by the company.
Strategic priorities
- Retail expansion beyond direct-to-consumer
- AG1 announced its first brick-and-mortar partnership with Costco on May 30, 2025, with stick packs in over 600 locations. The 2026 press adds a nationwide launch at The Vitamin Shoppe, tests of ready-to-drink offerings at Starbucks and vending machines in select airports.
- Broader product portfolio
- After 15 years with one product, AG1 launched AG1 Essential Gummies in August 2026, its first new product format in 16 years. Earlier launches include AG1 Pro (creatine-focused), AGZ Nightly Rest & Restore, and AG Omega3. AG1 Energy+ was previewed for later in August and an AG1 Ready-to-Drink line for next year.
- Clinical research and quality certification
- The CEO cites human clinical trials on the finished formula and NSF for Sport certification as differentiators. AG1 announced a $20 million commitment to research and discovery over the next three years.
- Deepening the core subscription audience
- Cole describes the core audience as high performers and says repeat customers are the largest growth driver. ClickZ reports over 90% of revenue comes from recurring customers.
- International expansion
- Cole says AG1 is already in many markets, mainly Europe and APAC, and will continue international expansion.
Investments and deals
- Research commitment
- A $20 million commitment to ongoing research and discovery over the next three years, announced alongside the Costco launch in 2025.
- Supply chain
- Some production moved from New Zealand to the US; Cole says the product is now also blended in the United States.
- Team
- Recent hires include CMO Paulie Dery, former CMO of Yeti, in August.
Challenges and risks
- Protecting focus while adding products
- Cole says the company does not want to lose its differentiation as it moves from one product at scale to a few more.
- Reformulating a product customers love
- The CEO calls upgrading the formula "a bit white-knuckle" because changes can affect taste or texture, and each change restarts third-party certification.
- Crowded market and lookalikes
- Cole says that in a crowded market with lots of lookalikes and knockoffs differentiation gets muddy. NutraIngredients notes Unilever bought greens gummy brand Grüns for $1.2 billion earlier in 2026.
- Offering a second option on site and in stores
- At NRF, Cole described the move from one product to two as white knuckle, asking what the site experience will be when customers have the option of two.
What leadership says
“to be the most trusted and recommended daily foundational nutrition products and routine”
“This retail partnership marks a significant strategic milestone in our business.”
“There is nothing I could say to a customer that would get them to be loyal if the quality weren't there”
Where a supplier can help
- Retail and channel launch support
- Retail expansion (Costco, The Vitamin Shoppe, Starbucks tests, airport vending) creates needs in retail execution, field merchandising and shopper analytics for a brand built on direct-to-consumer.
- Multi-product operations and supply chain
- New formats (gummies, creatine, ready-to-drink) and the move of some production from New Zealand to the US point to demand for co-packing, logistics, quality testing and certification services.
- Clinical evidence and research partners
- The $20 million research commitment and the focus on clinical trials of the finished formula suggest openings for research organisations and evidence-communication providers.
- Subscription retention and lifecycle tooling
- With over 90% of revenue reported from recurring customers and a stated need to keep subscribers across life stages, retention analytics and customer-lifecycle tools are relevant, especially as a second product changes the site experience.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like AG1?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Inside the ICE House, Episode 468: AG1 CEO Kat Cole on Health, Wellness, & the Foundational Nutrition Movement (ICE Experience 2025)
- AG1 is a privately held, subscription-based daily health drink (a green powder) that combines a multivitamin, pro and prebiotics and phytonutrients; Cole calls it "one of the fastest growing nutrition companies in the world".
- Cole says the founder bootstrapped it, took no outside capital and had "a little bit of debt"; when she joined in 2021 the business was "already doing 160 million in annual sales" and over four years "we've 3Xed the business".
- The product was made only in New Zealand when she joined; it is now also blended in the United States.
- Differentiators she names: NSF for Sport third-party certification, human clinical trials on the finished formula, and taste without sugars, gums or artificial sweeteners.
- Strategy: deepen the core (high performers), expand beyond direct-to-consumer into retail ("coming very soon"), add "a few other products, not many", and continue international expansion, mainly Europe and APAC.
- She says the largest growth driver is repeat customers telling family and friends, not podcasts or marketing.
- Company-stated clinical claims (attributed to Cole): four times the presence of beneficial gut bacteria and over 200% improvement in short chain fatty acid markers.
- Stated vision: "to be the most trusted and recommended daily foundational nutrition products and routine".
- AG1 Launches Nationwide Into Costco, Marking First Brick and Mortar Expansion (company press release)
- On May 30, 2025 AG1 announced its first brick-and-mortar retail partnership, with Costco, calling it "the brand's first major channel expansion into retail".
- The AG1 40 count single-serve stick packs are sold in over 600 Costco locations across the U.S. per the release subtitle.
- Kat Cole, CEO, says the company has grown "an incredible DTC business over the past 15 years" and now wants to reach "customers who prefer a physical retail experience".
- The company says AG1 Next Gen, the latest iteration with four gold standard clinical trials, is available exclusively on drinkag1.com.
- AG1 announced a $20 million commitment to ongoing research and discovery over the next three years.
- Kat Cole was announced as CEO in July 2024; AG1 describes itself as founded in 2010 with operations in North America, Europe and Asia Pacific.
- The company states AG1 is NSF Certified for Sport and third party certified free from hundreds of herbicides, pesticides and contaminants.
- Athletic Greens is 'ready to start saying yes' to new products. AG1 will expand and is projected to reach $600 million in revenue this year (Retail Brew, via Fortune)
- Retail Brew reports AG1 "is projected to reach $600 million in revenue this fiscal year by selling just a single product" solely direct to consumer, a model followed since 2010.
- At an NRF panel, CEO Kat Cole (who took over from founder Chris Ashenden in July) said the company is gearing up for "first steps" into new retail channels and products.
- She gave three reasons the company is ready: a strengthened supply chain (some production moved from New Zealand to the US), clinical trials to support a "science-driven message to consumers", and a team with retail experience.
- Recent hires include CMO Paulie Dery, former CMO of Yeti, in August.
- New channels include partnerships with 1 Hotels and True Food Kitchen, and a Shopify pop-up in SoHo.
- On loyalty Cole says "There is nothing I could say to a customer that would get them to be loyal if the quality weren't there".
- Unlocking the Next Chapter at AG1: Why Simplicity, Science, and Scale Still Win (ClickZ report on Kat Cole's Shoptalk 2025 keynote)
- ClickZ reports on Kat Cole's Shoptalk 2025 keynote: AG1 built a "$600M business with a single product" over 15 years.
- Per the article, over 90% of AG1's revenue comes from recurring customers.
- Cole says growth was built on referrals, and "Even at our peak, podcast traffic was a minority".
- The media mix is widening to TV, out-of-home, and partnerships with US Sailing and Ironman; creator partnerships only with existing AG1 users.
- The article says the audience is now evenly split by gender, with 60+ consumers among the fastest-growing segments.
- Cole links growth to customers using the drink to fill nutrition gaps left by appetite-reducing medications (GLP-1s).
- Next steps: retail after 15 years as DTC-only, and a second product that is "hard and complicated".
- AG1 bets on gummies to expand beyond its greens roots (NutraIngredients)
- AG1 launched AG1 Essential Gummies in August 2026, which NutraIngredients calls the brand's first new product format in its 16-year history.
- The trade outlet says AG1 has grown to "approximately $600 million in revenue over the past 16 years", up from close to $160 million in 2021, according to a 2024 projection shared by the privately held company.
- Retail expansion: a nationwide Costco launch in 2025 and The Vitamin Shoppe in 2026; AG1 has also tested ready-to-drink offerings at Starbucks and vending machines in select airports.
- Portfolio: AG1 Pro (creatine-focused, June), AGZ Nightly Rest & Restore (sleep), AG Omega3 and AG Omega3 + CoQ10, with AG1 Energy+ previewed for later in August and an AG1 Ready-to-Drink line planned for next year.
- Cole says over 30% of AG1 customers already stack creatine.
- Competitive context: Unilever bought greens gummy brand Grüns earlier in 2026 for $1.2 billion, per the article.
Questions about AG1
What does AG1 do?
AG1 (formerly Athletic Greens) is a global nutrition company founded in 2010. Its flagship AG1 is a daily health drink combining a multivitamin, pre and probiotics and phytonutrients, and it now also sells other formats such as gummies.
How much revenue does AG1 make?
AG1 is private and the documents give no audited figure. NutraIngredients reports approximately $600 million in revenue over the past 16 years, up from close to $160 million in 2021, according to a 2024 projection shared by the company.
Who leads AG1?
Kat Cole is Chief Executive Officer; AG1 announced her appointment in July 2024. She took over from founder Chris Ashenden.
What is AG1's strategy?
Cole describes it as growing the core, expanding and innovating in the product offering, expanding channels and continuing to grow internationally, on a foundation of brand and trust.
Where is AG1 sold?
AG1 was sold only direct to consumer for 15 years. It launched at Costco in the U.S. in 2025 and The Vitamin Shoppe in 2026, and operates in North America, Europe and Asia Pacific.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-19)